UOC
XAGEW

UBS O'Connor’s Longevity Health Holdings, Inc. Warrant XAGEW Stock Holding History

UBS O'Connor’s Portfolio XAGEW Stock Details XAGEW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-371,250
Closed -$11.3K – 471
2025
Q2 		$11.3K Hold
371,250
– – ﹤0.01% 349
2025
Q1 		$13.4K Hold
371,250
– – ﹤0.01% 306
2024
Q4 		$21.3K Hold
371,250
– – ﹤0.01% 381
2024
Q3 		$33K Hold
371,250
– – ﹤0.01% 431
2024
Q2 		$27.1K Hold
371,250
– – ﹤0.01% 466
2024
Q1 		$56.5K Hold
371,250
– – ﹤0.01% 438
2023
Q4 		$82.8K Hold
371,250
– – ﹤0.01% 417
2023
Q3 		$91K Buy
+371,250
New +$91.8K ﹤0.01% 473

Other funds holding XAGEW

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

UBS O'Connor's XAGEW Position: Q3 2025 in Review

UBS O'Connor sold out of Longevity Health Holdings, Inc. Warrant (XAGEW) in Q3 2025, closing a stake of 371,250 shares — an estimated $11.3K sold.

UBS O'Connor first reported a position in XAGEW in Q3 2023 and held it in 8 quarters. The position peaked at $91K in Q3 2023. 1 fund tracked by Wall St. Rank holds XAGEW as of Q3 2025.

  • UBS O'Connor reported no remaining Longevity Health Holdings, Inc. Warrant position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 371,250 Longevity Health Holdings, Inc. Warrant shares in Q3 2025, an estimated $11.3K.
  • UBS O'Connor first reported a position in Longevity Health Holdings, Inc. Warrant in Q3 2023 and held it in 8 quarters.
  • UBS O'Connor's Longevity Health Holdings, Inc. Warrant position peaked at $91K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Longevity Health Holdings, Inc. Warrant as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.